CAPRICOR THERAPEUTICS, INC. 10-K Cybersecurity GRC - 2024-03-11

Page last updated on April 11, 2024

CAPRICOR THERAPEUTICS, INC. reported their cybersecurity risk management and governance process in a yearly 10-K filed on 2024-03-11 08:30:52 EDT.

Filings

10-K filed on 2024-03-11

CAPRICOR THERAPEUTICS, INC. filed an 10-K at 2024-03-11 08:30:52 EDT
Accession Number: 0001558370-24-002861

Note: filing items unformatted. Drop us a note with the above URL to help us prioritize formatting it!

Item 1C. Cybersecurity.

ITEM 1C. CYBERSECURITY We operate in the biotechnology sector, which is subject to various cybersecurity risks that could adversely affect our business, financial condition, and results of operations, including intellectual property theft fraud extortion harm to employees violation of privacy laws and other litigation and legal risk and reputational risk. We have implemented a risk-based approach to identify and assess the cybersecurity threats that could affect our business and information systems. We use various tools and methodologies to manage cybersecurity risk that are tested on a regular cadence to the best of our ability. We also monitor and evaluate our cybersecurity posture and performance on an ongoing basis through regular vulnerability scans and penetration tests. Our business depends on the availability, reliability, and security of our information systems, networks, data, and intellectual property. Any disruption, compromise, or breach of our systems or data due to a cybersecurity threat or incident could adversely affect our operations, research, product development, and competitive position. They may also result in a breach of our contractual obligations or legal duties to protect the privacy and confidentiality of our stakeholders. Such a breach could expose us to business interruption, future lost revenue, ransom payments, remediation costs, liabilities to affected parties, cybersecurity protection costs, lost assets, litigation, regulatory scrutiny and actions, reputational harm, and harm to our vendor relationships. The company is currently in the process of implementing a more formalized cybersecurity program.


Company Information

NameCAPRICOR THERAPEUTICS, INC.
CIK0001133869
SIC DescriptionPharmaceutical Preparations
TickerCAPR - Nasdaq
Website
CategoryNon-accelerated filer
Smaller reporting company
Fiscal Year EndDecember 30